NO984290D0 - Pharmaceutically useful compounds - Google Patents

Pharmaceutically useful compounds

Info

Publication number
NO984290D0
NO984290D0 NO984290A NO984290A NO984290D0 NO 984290 D0 NO984290 D0 NO 984290D0 NO 984290 A NO984290 A NO 984290A NO 984290 A NO984290 A NO 984290A NO 984290 D0 NO984290 D0 NO 984290D0
Authority
NO
Norway
Prior art keywords
pharmaceutically useful
useful compounds
compounds
pharmaceutically
useful
Prior art date
Application number
NO984290A
Other languages
Norwegian (no)
Other versions
NO984290L (en
Inventor
John Bantick
Roger Bonnert
Peter Cage
David Donald
Mark Furber
Simon Hirst
Matthew Perry
Eifion Phillips
Original Assignee
Astra Pharma Prod
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605803.7A external-priority patent/GB9605803D0/en
Priority claimed from GBGB9610474.0A external-priority patent/GB9610474D0/en
Priority claimed from GBGB9610894.9A external-priority patent/GB9610894D0/en
Priority claimed from GBGB9700862.7A external-priority patent/GB9700862D0/en
Application filed by Astra Pharma Prod, Astra Ab filed Critical Astra Pharma Prod
Publication of NO984290D0 publication Critical patent/NO984290D0/en
Publication of NO984290L publication Critical patent/NO984290L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
NO984290A 1996-03-20 1998-09-16 Pharmaceutically useful compounds NO984290L (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9605803.7A GB9605803D0 (en) 1996-03-20 1996-03-20 Pharmaceutically-active compound
GBGB9610474.0A GB9610474D0 (en) 1996-05-18 1996-05-18 Pharmaceutically active compounds
GBGB9610894.9A GB9610894D0 (en) 1996-05-24 1996-05-24 Pharmaceutically useful compounds
GBGB9700862.7A GB9700862D0 (en) 1997-01-16 1997-01-16 Pharmaceutically useful compounds
PCT/SE1997/000471 WO1997034893A1 (en) 1996-03-20 1997-03-20 Pharmaceutically useful compounds

Publications (2)

Publication Number Publication Date
NO984290D0 true NO984290D0 (en) 1998-09-16
NO984290L NO984290L (en) 1998-10-27

Family

ID=27451427

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984290A NO984290L (en) 1996-03-20 1998-09-16 Pharmaceutically useful compounds

Country Status (19)

Country Link
EP (1) EP0888347A1 (en)
JP (1) JP2000506884A (en)
KR (1) KR20000064716A (en)
CN (1) CN1218472A (en)
AR (1) AR006520A1 (en)
AU (1) AU712141B2 (en)
BR (1) BR9708103A (en)
CA (1) CA2247814A1 (en)
CZ (1) CZ297798A3 (en)
EE (1) EE9800298A (en)
ID (1) ID16283A (en)
IL (1) IL126271A0 (en)
IS (1) IS4848A (en)
NO (1) NO984290L (en)
NZ (1) NZ331614A (en)
PL (1) PL328921A1 (en)
SK (1) SK118798A3 (en)
TR (1) TR199801861T2 (en)
WO (1) WO1997034893A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110749A1 (en) * 2001-03-07 2002-09-12 Bayer Ag Substituted aminodicarboxylic acid derivatives
JP2003002863A (en) * 2001-06-25 2003-01-08 Nippon Soda Co Ltd Method for producing benzoic acids, and new compound
US6642249B2 (en) 2001-07-04 2003-11-04 Active Biotech Ab Immunomodulating compounds
SE0102404D0 (en) * 2001-07-04 2001-07-04 Active Biotech Ab Novel immunomodulating compounds
DE10229762A1 (en) * 2002-07-03 2004-01-22 Aventis Pharma Deutschland Gmbh Pyrazoloisoquinoline derivatives for the inhibition of NFkappaB-inducing kinase
DE60311861T2 (en) * 2002-11-22 2007-11-22 Active Biotech Ab PYRAZOLOCHINOLINE WITH IMMUNOMODULATING EFFECT
EP1572689B1 (en) 2002-12-16 2009-03-11 Active Biotech AB Tetracyclic immunomodulatory compounds
EA009680B1 (en) * 2003-03-14 2008-02-28 Эвидекс Лимитед Immunomodulating heterocyclic compounds
GB0325644D0 (en) 2003-11-04 2003-12-10 Avidex Ltd Immuno ihibitory pyrazolone compounds
PA8619901A1 (en) 2003-12-12 2005-11-25 Wyeth Corp USEFUL KINOLINES IN THE TREATMENT OF CARDIOVASCULAR DISEASES
FR2870239B1 (en) * 2004-05-11 2006-06-16 Sanofi Synthelabo DERIVATIVES OF 2H- OR 3H-BENZO [E] INDAZOL-1-YLE CARBAMATE, THEIR PREPARATION AND THEIR THERAPEUTIC USE.
GB0411770D0 (en) * 2004-05-26 2004-06-30 Avidex Ltd Immuno inhibitory heterocyclic compouds
WO2006016093A1 (en) * 2004-08-09 2006-02-16 Avidex Limited Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors
GEP20115239B (en) 2006-10-31 2011-06-10 Pfizer Prod Inc Pyrazoline compounds as mineralocorticoid receptor antagonists
CN102372710A (en) 2010-08-18 2012-03-14 山东轩竹医药科技有限公司 Fused cyclic compound being taken as mineral corticoid recept antagonist
JPWO2012108511A1 (en) 2011-02-09 2014-07-03 日産化学工業株式会社 Pyrazole derivatives and pest control agents
ES2954572T3 (en) 2018-09-07 2023-11-23 Merck Patent Gmbh 5-morpholin-4-yl-pyrazolo[4,3-b]pyridine derivatives
US11753413B2 (en) 2020-06-19 2023-09-12 Incyte Corporation Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F inhibitors
WO2021257857A1 (en) 2020-06-19 2021-12-23 Incyte Corporation Naphthyridinone compounds as jak2 v617f inhibitors
WO2022006456A1 (en) 2020-07-02 2022-01-06 Incyte Corporation Tricyclic pyridone compounds as jak2 v617f inhibitors
KR20230057341A (en) 2020-07-02 2023-04-28 인사이트 코포레이션 Tricyclic urea compounds as JAK2 V617F inhibitors
WO2022046989A1 (en) 2020-08-27 2022-03-03 Incyte Corporation Tricyclic urea compounds as jak2 v617f inhibitors
WO2022140231A1 (en) 2020-12-21 2022-06-30 Incyte Corporation Deazaguaine compounds as jak2 v617f inhibitors
AR125273A1 (en) 2021-02-25 2023-07-05 Incyte Corp SPIROCYCLIC LACTAMS AS JAK2 INHIBITORS V617F

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524146A (en) * 1982-12-08 1985-06-18 Ciba-Geigy Corporation Certain -2-heterocycle substituted pyrazoloquinolines
JPS61112075A (en) * 1984-11-05 1986-05-30 Shionogi & Co Ltd Thienylpyrazoloquinoline derivative
SE8903564D0 (en) * 1989-10-26 1989-10-26 Pharmacia Ab NEW USE CONDENSED QUINOLINE COMPOUND
JPH05194515A (en) * 1991-07-31 1993-08-03 Kyowa Hakko Kogyo Co Ltd Condensed naphthyridine derivative

Also Published As

Publication number Publication date
EP0888347A1 (en) 1999-01-07
KR20000064716A (en) 2000-11-06
TR199801861T2 (en) 1998-12-21
CZ297798A3 (en) 1999-03-17
EE9800298A (en) 1999-02-15
SK118798A3 (en) 1999-03-12
NO984290L (en) 1998-10-27
ID16283A (en) 1997-09-18
JP2000506884A (en) 2000-06-06
WO1997034893A1 (en) 1997-09-25
PL328921A1 (en) 1999-03-01
IL126271A0 (en) 1999-05-09
NZ331614A (en) 2000-07-28
CN1218472A (en) 1999-06-02
BR9708103A (en) 1999-07-27
AR006520A1 (en) 1999-09-08
IS4848A (en) 1998-09-16
AU712141B2 (en) 1999-10-28
CA2247814A1 (en) 1997-09-25
AU2186797A (en) 1997-10-10

Similar Documents

Publication Publication Date Title
NO992347D0 (en) R ° rgripeanordning
ID19609A (en) HETEROSICLIC COMPOUNDS
ID19403A (en) HETEROSICLIC COMPOUNDS
ID16152A (en) TRIARIL COMPOUNDS
NO975894L (en) Foringsr ° rpakning
NO984290D0 (en) Pharmaceutically useful compounds
ID15904A (en) TIOFENOPIRIMIDINE COMPOUNDS
ID19430A (en) COMPOUND HETEROSICLIC COMPOUND
BR9709230A (en) Compound
ID19476A (en) PYRIDYLPIROL COMPOUNDS
BR9707051A (en) Compound
NO985766L (en) B ° lgeenergiomformer
NO303590B1 (en) L ° pehjul
NO992541D0 (en) R ° rbeskytter
DE69716924T2 (en) Phosphonate-NUCLEOTIDE COMPOUNDS
PT906288E (en) NEW COMPOUNDS
NO983683L (en) R ° rperforeringssystem
BR9705635A (en) Compounds
NO983116L (en) Svingd ° r
NO984943L (en) R ° rledningslagring
BR9711205A (en) Compound
DK0923594T3 (en) Bromothiacumicin compounds
NO305650B1 (en) L ° ftejekk
NO985395D0 (en) L ° fteanordning
NO990168D0 (en) R ° rforsegling